ResultsIQ

ResultsIQ › Latest results › Health X Platform Limited

Health X Platform Limited Q4 FY26 earnings call summary

NSE: HEALTHX · BSE: 533259

Earnings call of 12 Jun 2026, summarised by AI from the filing.

Health X Platform FY26 revenue ₹1,283 cr, PAT loss ₹1.4 cr; targets ₹6,000 cr by FY30 and demerges Microsec Resources.

Key takeaways

  1. FY30 target Targets ₹6,000 cr revenue by FY30: ₹4,000 cr B2B and ₹2,000 cr B2C.
  2. Demerger Finance division to demerge as Microsec Resources; 1 share for every 3 held.
  3. AI delay AI rollout delayed six months as market not ready; needs large capital.

Original filing on BSE

Health X Platform Limited Q1 FY27 results

As filed: Revenue ₹447 cr, EBITDA −₹8.4 cr, PAT ₹2.0 cr, EBITDA margin -1.9%.

Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹447 cr). Scored once a year-earlier consolidated quarter exists.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹374 cr, EBITDA −₹25.2 cr, PAT −₹13.0 cr, EBITDA margin -6.7%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹374 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +3.6% in 30 days (Nifty 500: +1.5%).

Past price moves after results do not indicate future moves. Not a recommendation.

Health X Platform Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.